The open-source AI model improves transparency in predicting how proteins interact with other molecules, which could speed up drug discovery.

The developers of OpenFold3 have released an early version of the tool, which they hope will one day perform on par with DeepMind’s protein-structure model.

OpenAI said it has reorganized its ownership structure and converted its business into a public benefit corporation.

OpenAI said Tuesday it has reorganized its ownership structure and converted its business into a public benefit corporation ...